Market Place
Sourcing Support
Araris Biotech Expands IP with Innate Pharma’s ADC Patents
24 Sep 2024 //
GLOBENEWSWIRE
Araris Biotech AG Appoints Dr. Ulf Grawunder to Scientific Advisory Board
13 Jun 2024 //
GLOBENEWSWIRE
Araris Biotech AG Presents Data at AACR Annual Meeting 2024
05 Apr 2024 //
GLOBENEWSWIRE
Araris Biotech AG to Present Data on Antibody-Drug Conjugate Candidates
06 Mar 2024 //
GLOBENEWSWIRE
Araris Biotech AG Announces Research Collaboration with Taiho Pharmaceutical
08 Nov 2023 //
GLOBENEWSWIRE
Araris Biotech AG Initiates Leadership Transition
04 Oct 2023 //
GLOBENEWSWIRE
Araris Biotech supported with CHF 2.5M Swiss accelerator grant from Innosuisse
08 May 2023 //
PHARMABIZ
Araris Biotech AG Supported with CHF 2.5M Swiss Accelerator Grant
05 May 2023 //
GLOBENEWSWIRE
Araris Biotech AG Acquires ARS Pharmaceutical’s Nectin-4 Antibody
17 Apr 2023 //
GLOBENEWSWIRE
Araris Presents Data Highlighting Stable and Efficacious Low Drug-Load ADCs
14 Apr 2023 //
GLOBENEWSWIRE
Araris Biotech AG Announces Strategic Investment with Samsung Ventures
11 Apr 2023 //
GLOBENEWSWIRE
Araris Biotech AG to Present Data at AACR Annual Meeting 2023
14 Mar 2023 //
GLOBENEWSWIRE
Araris Biotech AG to Present at the 22nd Annual PepTalk
19 Jan 2023 //
GLOBENEWSWIRE
Araris Biotech Appoints Filippo Mulinacci, Ph.D., MBA as Chief Business Officer
12 Oct 2022 //
GLOBENEWSWIRE
Araris Biotech AG Nabs $24M to Bring ADC, Linker Programs to Clinic
05 Oct 2022 //
BIOSPACE
Araris Biotech Closes $24 Million Financing Round
04 Oct 2022 //
GLOBENEWSWIRE
Araris Biotech AG to Present at Informa Connect’s Protein Therapeutics
21 Sep 2022 //
GLOBENEWSWIRE
Araris Biotech to Present at H.C. Wainwright PCDD Conference
28 Jun 2022 //
GLOBENEWSWIRE
Araris Biotech Presents PC Data on Anti-CD79b and Nectin-4 ADC Programs
08 Apr 2022 //
GLOBENEWSWIRE
Araris Biotech AG to Present at 12th Annual World ADC London 2022
29 Mar 2022 //
GLOBENEWSWIRE
Araris Biotech to Present PC Data at AACR
09 Mar 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.